Pooja Gogia

TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors

Alessandro Di Federico, Lingzhi Hong, Arielle Elkrief, Rohit Thummalapalli et autres

us, it, my (code pays fourni par la source)

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

Alessandro Di Federico, Lingzhi Hong, Arielle Elkrief, Rohit Thummalapalli et autres

us, it, my (code pays fourni par la source)

Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer

Arielle Elkrief, Meagan Montesion, Smruthy Sivakumar, Caryn Hale et autres

PURPOSE The impact of the intratumoral microbiome on immune checkpoint inhibitor (ICI) efficacy in patients with non–small-cell lung cancer (NSCLC) is unknown. Preclinically, intratumoral Escherichia is associated with a proinflammatory tumor microenvironment and decreased metastases. We sought to determine whether intratumoral Escherichia …

us (code pays fourni par la source)

Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy

Arielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, Chad Vanderbilt et autres

Anti-PD(L)-1 inhibition combined with platinum doublet chemotherapy (Chemo-IO) has become the most frequently used standard of care regimen in patients with non-small cell lung cancer (NSCLC). The negative impact of antibiotics on clinical outcomes prior to anti-PD(L)-1 inhibition monotherapy (IO) has been …

us, ca, fr (code pays fourni par la source)

Unmasking the Mimic: A Tale of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Challenging Diagnosis

S. Bhasin, Sanya Chandna, Pooja Gogia, Veena Dhawan

us (code pays fourni par la source)

Supplementary Tables from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Arielle Elkrief, Nicholas R. Waters, Natalie Smith, Anqi Dai et autres

Supplemental Tables S1-S5

Figure S5 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Arielle Elkrief, Nicholas R. Waters, Natalie Smith, Anqi Dai et autres

Figure S5

Figure S4 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Arielle Elkrief, Nicholas R. Waters, Natalie Smith, Anqi Dai et autres

Figure S4

Figure S1 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Arielle Elkrief, Nicholas R. Waters, Natalie Smith, Anqi Dai et autres

Figure S1

Figure S2 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Arielle Elkrief, Nicholas R. Waters, Natalie Smith, Anqi Dai et autres

Figure S2

Supplementary Tables from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Arielle Elkrief, Nicholas R. Waters, Natalie Smith, Anqi Dai et autres

Supplemental Tables S1-S5

Supplementary Tables from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Arielle Elkrief, Nicholas R. Waters, Natalie Smith, Anqi Dai et autres

Supplemental Tables S1-S5